CORDARONE

This brand name is authorized in Australia, Croatia, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug CORDARONE contains one active pharmaceutical ingredient (API):

1	Amiodarone UNII 976728SY6Z - AMIODARONE HYDROCHLORIDE
	Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
	Read more about Amiodarone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CORDARONE X 100 Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
CORDARONE X Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BD01	Amiodarone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2343H, 2344J
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01408051, 02156723, 02235693, 02235701, 02235718, 16582211, 16582234, 16582240
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.175-1-04-07
EE	Ravimiamet	1016233, 1016244, 1730753
FI	Lääkealan turvallisuus- ja kehittämiskeskus	142307, 421180
FR	Base de données publique des médicaments	60662396, 62305927, 64408662, 68973926
GB	Medicines & Healthcare Products Regulatory Agency	13396, 13423, 209123
HK	Department of Health Drug Office	27294, 27296
HR	Agencija za lijekove i medicinske proizvode	HR-H-204962082, HR-H-451337551
IT	Agenzia del Farmaco	025035015
LT	Valstybinė vaistų kontrolės tarnyba	1000504, 1016571, 1088663, 1092754
MT	Medicines Authority	MA1359/01401, MA1359/01402
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	148M81, 276M81
NL	Z-Index G-Standaard	15731839
NL	Z-Index G-Standaard, PRK	25119
NZ	Medicines and Medical Devices Safety Authority	3467, 3468, 3469
PL	Rejestru Produktów Leczniczych	100015820, 100015850, 100272557, 100274119, 100326862, 100330881, 100334206, 100338322, 100339824, 100344506, 100346586, 100346764, 100377894, 100385741, 100413800, 100429697, 100456045
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64483001, W64483002
SG	Health Sciences Authority	00852P, 09784P
TN	Direction de la Pharmacie et du Médicament	6260032, 9263071
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809018020, 8699809759107
ZA	Health Products Regulatory Authority	P/6.2/165, S/6.2/384